Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment

By Adam Fleisher, B. Sowell, Curtis Taylor, Anthony Gamst, R. C. Petersen, Leon J. Thal. 2007

232 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

RETAIN: An Interpretable Predictive Model for Healthcare using Reverse Time Attention Mechanism (2016, methodology): “…attention weights that focus on each coordinate of the visit embedding We use two RNNs, RNN α and RNN β , to separately generate α ’s and β ’s as follows, where g i ∈ R p is the hidden layer of RNN α at time step i , h i ∈ R q the hidden layer of RNN β at time step i and The hyperparameters…”
Molecular mechanisms of neurodegeneration in Alzheimer's disease. (2010, background): “Therapeutical strategies for Alzheimer’s Disease The focus in past years for AD therapies has been to improve memory by activating cholinergic neurotransmission (159), and more recently anti-oxidants (160) and blockers of calcium channels (161) have been utilized.”